Jefferies analyst Raj Denhoy raised the price target on Medtronic, Inc. (NYSE: MDT) to $155.00 (from $145.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Medtronic, Inc. (MDT) PT Raised to $142 at Raymond JamesAugust 25, 2021 7:24 AM Medtronic, Inc. (MDT) PT Raised to $148 at Truist SecuritiesAugust 25, 2021 7:22 AM Medtronic, Inc. (MDT) PT Raised to $149 at UBS After Reiterating Organic Guidance Despite HeadwindsAugust 25, 2021 7:07 AM Medtronic (MDT) Tops FQ1 Views, Analysts Raise PTs on 'Solid' PrintAugust 25, 2021 6:52 AM Medtronic, Inc. (MDT) PT Raised to $151 at Wells FargoAugust 25, 2021 6:50 AM Medtronic, Inc. (MDT) PT Raised to $145 at StifelAugust 25, 2021 6:33 AM Medtronic, Inc. (MDT) PT Raised to $145 at Stifel Seeing 4 Key Points to the QuarterAugust 25, 2021 6:32 AM Medtronic, Inc. (MDT) PT Raised to $153 at CitiAugust 25, 2021 6:03 AM UPDATE: Medtronic, Inc. (MDT) Guidance Includes a Delta Headwind Morgan Stanley Sees Room for Raises, PT Raised to $154August 25, 2021 3:09 AM Medtronic, Inc. (MDT) PT Raised to $152 at Needham & Company, Following EarningsAugust 24, 2021 2:05 PM Medtronic (MDT) Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic StenosisAugust 24, 2021 9:15 AM Medtronic Announces FDA Approval of Next-Gen TAVR System for Treatment of Symptomatic Severe Aortic StenosisAugust 24, 2021 9:15 AM Form 8-K Medtronic plc For: Aug 24August 24, 2021 6:51 AM Medtronic (MDT) Tops Q1 EPS by 9c, Raises EPS GuidanceAugust 24, 2021 6:47 AM Medtronic Reports First Quarter Fiscal 2022 Financial ResultsAugust 24, 2021 6:45 AM